Support Ward 7 Business and Alan Straton’s Campaign for Candidate Councillor
PE Vein is the most advanced treatment centre in the Eastern Cape.
At PE Vein it is our vision to develop excellence in the management of venous disorders, specifically varicose veins.
We aim to achieve this by assembling a multidisciplinary team of clinicians who are all passionate about achieving academic and clinical excellence.
Currently, PE Vein is the most advanced treatment centre in the Eastern Cape. We do not just utilize the latest equipment for the treatment of varicose veins, but also offer the CLaCS cosmetic treatment for spider veins – the first of its kind in Africa and 1 of 10 countries in the world!
The management of venous diseases is a specialised field that has gone long-neglected in South Africa. The open surgery alternate vein treatments (VNUS, CLaCS, foam- & micro sclerotherapy, ambulatory phlebectomy) that we offer, have been recognized at a gold treatment standard level globally for the past ten years. However, these vein treatments were not previously available in South Africa.
Not only are these varicose vein treatments pain-free and effective for the treatment of venous diseases, but they are also conducted as in-room procedures and do not require hospitalization.
In using these advanced and trusted vein treatment methods, PE Vein aims to revolutionise the assessment and treatment of varicose veins, spider veins and venous ulcers in Gqeberha.
226 Cape Road, Mill Park, Ward 7, Gqeberha, Nelson Mandela Bay, Eastern Cape, South Africa
Alan Straton
Latest posts by Alan Straton (see all)
- Vanilla, Caramel or Hazelnut? Coffee Syrups Get Cafés Ready for Iced Coffee - 20 November 2026
- Chilla açaí by Polpanorte Brings Brazil’s Original açaí to South Africa - 19 November 2026
- Chocolate, Banana and Bubblegum Milkshake Syrups for the School Holidays - 19 November 2026
- Trusting Trusts Offers Plain-Language Reviews of Older Trusts - 19 November 2026
- Sticker Papers Pro Sets Out When Outdoor Print Needs Polymeric Film - 19 November 2026
